Part,  Chapter, Paragraph

1   II,     5.  6.  6|      SJ, O'Fallon WM, Melton LJ, III (1993): Population-based
2   II,     5.  6.  6|   1001-1005~Cooper C, Melton LJ, III (1992): Epidemiology
3   II,     5.  6.  6|       BMJ 317:111-115~Melton LJ, III (1995): Epidemiology
4   II,     5.  6.  6|  Edited by: Riggs BL, Melton LJ, III). Lippincott-Raven
5   II,     5.  6.  6| Publishers, pp 225-47~Melton LJ, III (2003): Adverse outcomes
6   II,     5.  8.  7|       Henriksen BM, Petersen LJ, Backer V (2007): The prevalence
7   II,     5. 11.  7|        de Rijke JM, Schouten LJ, Hillen HF et al (2000):
8  III,    10.  1.  3|     513-530.~Burke V, Beilin LJ, Milligan R, Thompson C (